Lv2
130 积分 2023-08-18 加入
Changing cancer survival in China during 2003–15: a pooled analysis of 17 population-based cancer registries
2小时前
待确认
Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial
1年前
已完结
子宫颈胃型腺癌临床诊治中国专家共识（2023年版）
1年前
已完结
皖公网安备34019202002308
